Menopause is an Economic Issue: The Retention Argument Your Board Hasn't Heard Yet
Published on . Last updated on . See changes
Menopause is classified by most UK employers as a health and wellbeing issue. The more accurate classification is a workforce planning and retention issue. When experienced, senior women leave or reduce their working hours because their employer has not provided adequate support, the financial cost sits on the P&L – in recruitment fees, onboarding time, and institutional knowledge that cannot be quantified on a spreadsheet but can certainly be felt in the business. Here is the case for treating menopause support as a Finance Director conversation, not just an HR one.

The business case for menopause support in the workplace does not rest on compassion. It rests on workforce economics. The employees most likely to be affected by menopause symptoms – women aged 45 to 55 – include many of an organisation's most experienced managers, specialists and leaders. When those employees leave, reduce their hours, or disengage from their roles because their employer has not provided adequate support, the financial consequences are real and measurable. This piece sets out the retention argument in terms that Finance Directors and boards can evaluate – and the benefits design response that addresses the risk.
Why Menopause is a Workforce Planning Issue, Not a Wellbeing One
The categorisation matters. A wellbeing issue sits in the HR function, attracts a limited budget, and is measured in employee satisfaction scores. A workforce planning issue sits in the Finance function, attracts a cost-benefit analysis, and is measured in headcount stability, recruitment cost, and productivity impact. Menopause-related attrition is the latter.
The CIPD's guide for people professionals, Menopause at work, notes that for some women symptoms are so severe that they need to take time off or leave their job altogether. The CIPD's 2023 survey of 2,185 working women aged 40 to 60 included 1,531 who had experienced menopause symptoms. Of those, 17% had considered leaving work because of a lack of support, and a further 6% had left. The Fawcett Society's 2022 survey of 4,014 women aged 45 to 55 found that one in ten who had been employed during the menopause had left a job because of their symptoms, and 14% had reduced their hours. Applied to the seniority profile of most organisations, figures like these can represent a material share of the senior female talent pipeline.
This is not a niche issue affecting a small number of employees. ONS Annual Population Survey data shows that women in their late forties and early fifties are a large and highly economically active part of the UK workforce – 83% of women aged 45 to 54 are in work or looking for work. The overlap between this group and the workforce population affected by perimenopause and menopause is direct and significant. Employers who are not addressing this are carrying a retention risk that is not reflected in their workforce planning models.
The Attrition Profile: Who's Leaving and What it Costs to Replace Them
Many of the employees at risk of leaving because of unaddressed menopause symptoms are not junior staff. Women aged 45 to 55 include experienced managers, senior professionals and leaders with a decade or more of institutional knowledge. The replacement cost for these employees is significantly higher than for entry or mid-level roles.
For a senior professional or manager – typically a role requiring specialist knowledge or team leadership responsibility – replacement can cost a substantial share of annual salary. That cost includes recruitment, onboarding, reduced productivity during the ramp-up period and lost institutional knowledge. One UK study by Oxford Economics (2014) put the average cost of losing an employee earning £25,000 or more at £30,614, across five sectors. Most of that was lost output while the new hire got up to speed. For an employer losing two or three senior employees a year to menopause-related attrition, that adds up to a board-level financial exposure.
The calculation for Finance Directors is straightforward: identify the number of women aged 45 to 55 in the organisation, estimate the proportion who may be experiencing significant symptoms (the CIPD data provides a reasonable basis for this), apply the replacement cost for their seniority band, and compare that figure to the cost of implementing a meaningful menopause support programme. In many organisations, the programme will cost less than the attrition risk it addresses. Run the numbers for your own workforce: the answer depends on how many women you employ in the age band and what it costs to replace them.
The Productivity Impact: Absence, Presenteeism, and the Performance Gap
Attrition is the most visible cost, but it is not the only one. The CIPD's menopause guidance documents the extent to which menopause symptoms affect productivity for employees who remain in post but receive no support. The symptoms – which can include cognitive difficulties, fatigue, disrupted sleep, anxiety, and physical discomfort – are not conducive to high performance in demanding roles. Presenteeism among this group (attending work while symptomatic and unable to perform effectively) is well documented. In the CIPD's 2023 survey, 79% of working women negatively affected at work by menopause symptoms said they had felt less able to concentrate, and 35% said they had made more mistakes. Its cost to the business is hard to measure.
Absence is also affected. Menopause symptoms that are not managed – either medically or through workplace support – lead to increased sickness absence. For Finance Directors tracking absence cost as a percentage of payroll, the contribution of unaddressed menopause symptoms is difficult to isolate but not difficult to estimate once the workforce demographics are examined.
The performance gap – the difference between what an experienced senior employee delivers when appropriately supported and what they deliver when managing significant symptoms without support – represents a real but unmeasured cost. It does not appear in the accounts. It appears in missed deadlines, team performance, client relationship quality, and strategic output. These are the costs that are hardest to quantify and easiest to underestimate.
What Employers Are Currently Doing – and Why Most of it isn't Working
Where employers do act on menopause, the most common measure is a written policy – often alongside a link to an Employee Assistance Programme – yet in the CIPD's 2023 survey only around a quarter (24%) of working women said their organisation had a menopause policy or other support at all. For the majority of affected employees, this is insufficient. A policy document signals intent; it does not provide support. An EAP link puts the burden of navigation on the employee at a point when she may have the least capacity to navigate it.
In the same Fawcett Society survey, 81% of those who had worked during the menopause said their employer had not provided menopause training for managers. Line managers are the people in the best position to provide immediate support. A menopause policy that exists at the organisational level but has not been communicated to, or understood by, the line managers responsible for implementing it is a policy that does not function.
Acas guidance and the CIPD's 2023 research point to three things employers need for their menopause provision to work: their line managers have been trained and are confident having conversations about menopause; their HR and benefits provision includes flexible working arrangements that can be accessed without a protracted process; and their culture communicates that using this provision is both acceptable and expected, rather than a sign of vulnerability or special treatment.
The Commercial Case: What Retaining One Additional Senior Leader is Worth
The commercial case for menopause support does not require complex modelling. It requires two inputs: the replacement cost for a senior employee in the relevant role, and the cost of the menopause support programme being considered.
As an illustrative framework: a senior manager or experienced professional in a UK business might be on a total remuneration package of £70,000 to £100,000. The replacement cost – including recruitment agency fees (often charged at around 15–20% of first-year salary, and more for senior or executive search), onboarding time, management bandwidth consumed during the hiring process, and the productivity gap during the months it takes a new hire to reach full effectiveness – is estimated at between half and twice annual salary in Gallup's US research. We use 50% to 100% here for illustration. That is £35,000 to £100,000 per departure.
If a meaningful menopause support programme – covering manager training, flexible working facilitation, enhanced EAP access, and benefits adjustments – costs £10,000 to £20,000 per year to operate, and that programme retains two senior employees who would otherwise have left, the return on investment is immediate and substantial. The risk is not spending the money. The risk is not spending the money and absorbing the attrition cost instead.
The Finance Director Test
Solving the Attrition Problem
What a Serious Menopause Support Framework Looks Like in Practice
The Acas menopause at work guidance provides a clear framework for employers building or reviewing their provision. (Updated 16 October 2026: The Employment Rights Act 2025 allows the government to require employers in Great Britain with 250 or more employees to publish equality action plans, including support for employees going through the menopause. Employers of that size can already publish a voluntary plan, and the government says plans will become mandatory from spring 2027, subject to legislation. Acas has since updated its menopause guidance to cover these plans.) The components that carry the most practical weight are:
A written menopause policy. This should do more than state that the employer takes menopause seriously. It should set out what support is available, how to access it, what adjustments can be requested, and what the process is. Signposting a policy without specifying what it contains is not a policy – it is an aspiration.
Manager training. Line managers are the primary point of contact for employees needing support. If they are not trained and confident in how to respond, the policy fails at the first point of implementation. Training does not need to be extensive – even an hour of structured guidance can improve a manager's ability to have an effective conversation.
Flexible working access. Many menopause symptoms are manageable if the employee has control over their working environment, schedule, or location. A flexible working policy that is genuinely accessible – not one that requires a formal application process with a lengthy decision timeline – is one of the most effective interventions available.
Benefits that address the specific needs of this group. Enhanced EAP access with specific menopause pathways, private health cover that includes menopause consultations, and wellbeing benefits that support the management of symptoms are all relevant. The benefits should be communicated specifically – not buried in a generic benefits guide – so that affected employees know they exist.
A culture that normalises using the provision. The most carefully designed policy will underperform if the workplace culture makes using it feel like an admission of incapacity. Senior leadership visibility – including male leaders explicitly supporting menopause provision – is a strong signal that the policy is genuine.
The Benefits Design Question: Which Elements of a Benefits Package Actually Help
The benefits most directly relevant to menopause support are not always framed as menopause-specific. Flexible working benefits, health cash plans, enhanced private medical cover, and EAP counselling provision all serve this population – but only if they are communicated in a way that makes their relevance to menopause explicit.
An employee navigating perimenopause symptoms who does not know her employer offers private GP consultations, or who has not been told that her EAP includes menopause-specific mental health support, is not receiving the benefit – even though the employer is paying for it. This is the Benefit Literacy Gap in its most direct form: the employer has funded the provision, but the employee cannot use it because she does not know it exists or how to access it.
The decision support function – helping employees navigate to the right benefit at the right point in their working life – is exactly where Perky's Benefit Intelligence Platform operates. Benefits that are discoverable and explained in the context of the employee's situation are more likely to be used than benefits listed in a static catalogue.
How Finance Should Model This – From Attrition Cost to Programme Cost
The modelling framework for Finance Directors is a four-step calculation:
Identify the at-risk population. Use payroll data to establish the number of female employees aged 45 to 55. This is the population for whom menopause-related attrition is a plausible risk.
Apply a realistic attrition estimate. In the CIPD's 2023 survey, 6% of working women aged 40 to 60 with menopause symptoms had left work because of a lack of support, and a further 17% had considered it. Neither figure is an annual rate, so spread the 6% over the years your employees spend in the age band: 6% over ten years is about 0.6% a year. Treat the 17% as a measure of risk, not expected departures.
Calculate the replacement cost per departure. Use the organisation's actual recruitment cost data – or a conservative estimate of 50% of annual salary if specific data is not available – multiplied by the number of expected departures.
Compare to programme cost. Set the expected attrition cost against the cost of implementing and running a meaningful menopause support programme for one year. If the attrition cost exceeds the programme cost, the investment case is made without reference to wellbeing arguments, cultural values, or policy benchmarking.
Explore the Perky Solution
Frequently Asked Questions
The business case rests on retention economics. Many of the employees most affected by menopause symptoms are among the most experienced in the organisation. Losing them to menopause-related attrition carries a replacement cost that, in many organisations, will be higher than the cost of providing adequate support. In the CIPD's 2023 survey, 17% of working women aged 40 to 60 who had experienced menopause symptoms had considered leaving work because of a lack of support, and a further 6% had left. Applied to a specific organisation's workforce demographics and replacement cost data, figures like these can produce a clear investment case.
A functional menopause policy should specify: what support is available and how to access it; what adjustments can be requested and through what process; the training provided to line managers; how the policy interacts with absence management procedures; and who to contact for advice. Acas's menopause at work guidance sets out what a menopause policy could cover and recommends reviewing related policies, such as flexible working and absence management.
The CIPD menopause guidance documents the impact of symptoms – including cognitive difficulties, fatigue, anxiety, and disrupted sleep – on workplace performance. The effect manifests both as increased sickness absence and as presenteeism: employees who attend work but are not able to perform at full capacity because symptoms are not managed. Neither effect is fully captured in standard absence data, which is one reason the cost is systematically underestimated.
The tax treatment depends on the specific benefit. Medical or health-related benefits provided through a group private medical insurance scheme may be subject to Benefit-in-Kind tax. Benefits delivered through the EAP – which typically covers counselling and mental health support – are generally exempt from tax where they meet HMRC's qualifying conditions. Flexible working arrangements carry no BIK charge. Employers should confirm the tax position of specific benefits with their adviser before communicating any tax-free status to employees.
The total cost of replacing a senior employee typically includes: recruitment agency fees (often charged at around 15–20% of first-year salary, and more for senior or executive search); management time spent on the hiring process; onboarding and training cost; the productivity gap during a new hire's first months in the role; and the loss of institutional knowledge, client relationships, and team capability that the departing employee carried. Estimates vary: Gallup's US research puts it at between half and twice annual salary. We use 50% to 100% of annual salary as an illustrative planning assumption for many senior roles. The real figure will vary significantly by sector, role and seniority level, so use your own recruitment and productivity data where you have it.
Support reduces turnover by addressing the specific factors that drive menopause-related exits: unmanaged symptoms, inflexible working arrangements, unsupportive line managers, and lack of access to appropriate health and wellbeing provision. In the CIPD's 2023 survey, women with menopause symptoms who felt unsupported by their employer or manager were more than twice as likely to have considered quitting as those who felt supported. They were also around five times as likely to have left work. That is an association from one survey, not proof that a particular programme will prevent exits, so model the effect conservatively. In the Fawcett Society's 2022 survey, most women whose employers had taken steps such as manager training or an absence policy said those steps were helpful.
Change log
Added a note that the CIPD has revised its employee turnover and retention factsheet, which now explains how to measure turnover and retention rather than the cost of losing employees.
The downloadable menopause board business case template has been updated for 2026/27. The edition accurate at the date this post was published is archived here.
Added a note that the Employment Rights Act 2025 allows the government to require employers with 250 or more employees to publish equality action plans, including support for employees going through the menopause. The government says these will become mandatory from spring 2027, subject to legislation.
Thanks for reading!
More Posts